PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-kappaB activation.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31520915 ↗2019Reported benefit

Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-kappaB activation.

MouseEndotoxin/LPSC57BL/6maleintragastricPretreatment for 10 days, with the injury induced 2 h after the final dose

Model: Lipopolysaccharide (50 microgram/kg) plus D-galactosamine (800 mg/kg) induced acute liver injury

Helenalin reduced histopathological liver damage, serum aminotransferase and bilirubin levels, hepatocyte apoptosis, oxidative stress and inflammatory cytokine production in lipopolysaccharide/D-galactosamine-induced acute liver injury.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.